Dr. Himisha Beltran, MD – New York, NY

Overview of Dr. Beltran

Dr. Himisha Beltran is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital. She received her medical degree from New York Medical College and has been in practice 18 years. She is one of 433 doctors at Dana-Farber Cancer Institute and one of 364 doctors at Brigham and Women's Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

• New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2008 - 2011

• University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007

• New York Medical CollegeClass of 2004

Certifications & Licensure

• MA State Medical License 2019 - 2025

• NY State Medical License 2008 - 2019

• PA State Medical License 2007 - 2008

• American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

• Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with ...

  Nixon, A., Liu, Y., Yang, Q., Luo, B., Starr, M., Brady, J., Kelly, W., Halabi, S., Beltran, H., Morris, M., George, D., Armstrong, A.> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 12

• Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.

  Serritella, A., Beltran, H., Lotan, T., VanderWeele, D., Karzai, F., Madan, R., Hussain, M.> ;The Oncologist. 2024 Jan 11

• Non-invasive detection of neuroendocrine prostate cancer through targeted cell-free DNA methylation.

  Franceschini, G., Quaini, O., Mizuno, K., Orlando, F., Ciani, Y., Ku, S., Sigouros, M., Rothmann, E., Alonso, A., Benelli, M., Nardella, C., Auh, J., Freeman, D., Hanr...> ;Cancer Discovery. 2024 Jan 10
• Join now to see all

Journal Articles

• Activity of Platinum-Based Chemotherapy in Patients with Advanced Prostate Cancer with and Without DNA Repair Gene Aberrations  

  Himisha Beltran, Che-Kai Tsao, Tomasz M Beer, JAMA Network Open

Press Mentions

• The Challenge of Finding New Tools to Fight Prostate CancerSeptember 9th, 2021

• BET Inhibitors Show Promise in Overcoming Lineage Plasticity, a Newly Recognized Form of Resistance to Prostate Cancer DrugsJune 18th, 2021

• Dana-Farber Cancer Institute, a Pioneer in Cancer Care and Research, Joins Caris' Precision Oncology AllianceFebruary 16th, 2021

• Join now to see all

Professional Memberships

Hospital Affiliations